Cell Therapy Instruments Market to Grow at a CAGR of 13.2% to reach US$ 32,477.15 Million from 2020 to 2027

[Research Report] The cell therapy instruments market was valued at US$ 12,340.03 million in 2019 and is projected to reach US$ 32,477.15 million by 2027; it is expected to grow at a CAGR of 13.2% from 2020 to 2027.

Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. For instance, a person who has cancer is injected with T cells during his/her course of immunotherapy. The  cell therapy instruments ranges from injections to surgical implantation using special devices. Cell therapy has applications in a large number of diseases such as nervous system disorders, cancer, cardiac conditions (myocardial infarction and heart failure), diabetes mellitus, bones and joints, genetic disorders, and wounds of the skin and soft tissues.
The scope of the cell therapy instruments market includes product, cell type, process, end user, and region. The market for cell therapy instruments is analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the cell therapy instruments market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world.

Lucrative Regions for Cell Therapy Instruments Market

Get more information on this report : Request Free Sample PDF

Market Insights

Increasing Developments in Cell Therapy Manufacturing

The increasing research activities in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to efficiently treat genetic disorders and improve immune system. Various market players provide consumables such as reagents kits, enzymes, instruments, equipment, and software to conduct a wide range of cell therapy processes.

The use of equipment is important for the production of cell therapies such as T cells, HSC, NSC, PSC, and MSC. These cell therapy products are derived from human or animals cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies help preventing contamination and allows scaling up the production. For instance, companies such as Corning Incorporated; Thermo Fisher Scientific Inc.; Hitachi Chemical Advanced Therapeutics Solutions, LLC; Invetech; Miltenyi Biotec; and Cytiva (General Electric Company) have introduced various equipment and consumables for the cell therapy.

The companies operating in the market are continuously engaged in strategic developments to enhance the product portfolio of cell therapy. For instance, in June 2018, Hitachi Chemical Advanced Therapeutics Solutions, LLC and Invetech entered into a collaborative agreement to commercialize the Counter-Flow Centrifugation system (CFC), an automated platform for cell therapy manufacturing.

Similarly, in May 2019, Cytiva (General Electric Company) commercially introduced a chronicle automation software for cell therapy. The chronicle-automated software comprises a unified digital space that monitors all manufacturing operations and supply chain logistics with real-time data acquisition and notifications. Its electronic batch records trace every manufacturing step with automation and eSOPs designed for specific processes to manage deviations and promote adherence to protocol.

In May 2019, Thermo Fisher Scientific Inc. collaborated with Scinogy to develop and commercialize instruments and reagent systems. This partnership aims to provide a manufacturing system to improve cell and gene therapy, manufacturing productivity, and scalability. Such strategic developments made by the companies are likely to provide technically advanced cell therapy instruments in the market.

Cell Therapy Instruments Product - Based Insights

Based on product, the cell therapy instruments market is segmented into consumables, equipment, and systems and software. The consumables segment held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period. Further, the equipment segment is sub-segmented into single-use equipment, cell–processing equipment, and other equipment. The cell processing equipment segment held the largest market share in 2019; whereas, the single-use equipment segment is expected to grow at the fastest CAGR during the forecast period.

Global Cell Therapy Instruments Market, by Product – 2019 & 2027

Get more information on this report : Request Free Sample PDF

Cell Type -Based Insights

Based on cell type, the cell therapy instruments market is segmented into human cells and animal cells. The human cells segment held a larger share of the market in 2019, and is estimated to register a higher CAGR in the market during the forecast period. The human cells segment is further sub-segmented into differentiated cells, and stem cells. The stem cell segment held a larger market share in 2019, and is expected to grow at a faster CAGR during the forecast period.

Process -Based Insights

Based on process, the cell therapy instruments market is segmented into cell processing, process monitoring and quality control, and cell preservation, distribution, and handling. The cell processing segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.

End User -Based Insights

Based on end user, the cell therapy instruments market is segmented into research institutes, life science research companies, and other end users. The life science research companies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Inorganic strategies such as partnerships, merger and acquisition are commonly adopted by companies to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally. The market players operating in the cell therapy instruments market also adopted organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

By Product

• Consumables
• Equipment
  • Single-Use Equipment
  • Cell Processing Equipment
  • Other Equipment
• Systems and Software

By Cell Type                                                           

• Human Cells
  • Differentiated Cells
  • Stem Cells
• Animal Cells

By Process

• Cell Processing
• Process Monitoring and Quality Control
• Cell Preservation, Distribution, and Handling

By End User

• Research Institutes
• Life Science Research Companies
• Other End Users

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
• South and Central America (SCAM)
  • Brazil
  • Argentina

Company Profiles

• Thermo Fisher Scientific Inc.
• MERCK KGaA
• Lonza
• Cytiva (GE Healthcare Life Sciences)
• Terumo Corporation
• BD
• Miltenyi Biotec
• STEMCELL Technologies Inc.
• Sartorius AG
• Danaher Corporation (Beckman Coulter Inc.),